Micro-doses of Physical Activity for COPD (NCT05553223)
Can Micro-doses of Physical Activity Offset the Negative Cardiovascular Consequences of Being Sedentary in Patients With COPD?
🩺 Plain-English Summary (8th-Grade Level)
Chronic obstructive pulmonary disease (COPD) is a disease of the lungs that makes it hard for people to breath. Those with COPD spend considerably more time sitting and lying and less time performing physical activity than healthy individuals. Those who are the most sedentary have a greater risk of heart and blood vessel disease, which may lead to an early death. This project will investigate the effect of sitting still for 3 hours on blood vessel health in individuals with COPD. It will also investigate whether breaking up the amount of time patients sit with regular short bouts of walking (5 minutes each hour) at a comfortable pace chosen by the patient can have a positive effect on maintaining the health of their blood vessels. It is hypothesized that blood vessel health will be worse after 3 hours of sitting compared to when the sitting is broken up by short bouts of walking.
Who can join: Review the eligibility criteria below.
Location: University of British Columbia — Kelowna, British Columbia
🧪 Interventions in This Study
- Microdoses of activity (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of British Columbia — Kelowna, British Columbia
📞 Contact the Study Coordinator
Phone: (250) 807-9676
Email: neil.eves@ubc.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Obstructive Pulmonary Disease
- Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects — Hershey, Pennsylvania
- A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD — Chandler, Arizona
- Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD — Miami, Florida
- A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD — Bakersfield, California
- A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Birmingham, Alabama
- Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease — Birmingham, Alabama
Explore by condition: All Chronic Obstructive Pulmonary Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.